Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Yifeng Pharmacy Chain (603939.SS)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date	Stock Price (Rmb)	Price Target (Rmb)	Rating
2022-04-15	21.60	51.19	Buy
2022-05-18	25.29	35.714	Buy
2022-08-30	31.32	38.988	Buy
2023-04-11	34.01	44.643	Buy
2023-05-05	31.18	41.075	Buy
2023-08-29	30.51	40.417	Buy
2023-10-31	27.30	37.50	Buy
2024-04-30	36.62	41.25	Buy
2024-10-08	27.56	34.00	Buy
2024-11-01	26.10	38.00	Buy
2025-04-29	28.00	40.00	Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.